|
Volumn 2012, Issue , 2012, Pages 335-341
|
Have drug combinations supplanted stem cell transplantation in myeloma?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BORONIC ACID DERIVATIVE;
BORTEZOMIB;
PYRAZINE DERIVATIVE;
ADULT;
AGED;
ARTICLE;
DISEASE FREE SURVIVAL;
DRUG THERAPY;
FEMALE;
GENOMICS;
HUMAN;
MALE;
METHODOLOGY;
MIDDLE AGED;
MULTIPLE MYELOMA;
ONCOLOGY;
PROPORTIONAL HAZARDS MODEL;
STEM CELL TRANSPLANTATION;
TIME;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BORONIC ACIDS;
DISEASE-FREE SURVIVAL;
DRUG THERAPY;
FEMALE;
GENOMICS;
HUMANS;
MALE;
MEDICAL ONCOLOGY;
MIDDLE AGED;
MULTIPLE MYELOMA;
PROPORTIONAL HAZARDS MODELS;
PYRAZINES;
STEM CELL TRANSPLANTATION;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 84879385304
PISSN: None
EISSN: 15204383
Source Type: Journal
DOI: 10.1182/asheducation.v2012.1.335.3792205 Document Type: Article |
Times cited : (10)
|
References (0)
|